TONELLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.242
AS - Asia 8.755
EU - Europa 7.886
SA - Sud America 1.331
Continente sconosciuto - Info sul continente non disponibili 359
AF - Africa 226
OC - Oceania 74
Totale 35.873
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.740
IT - Italia 3.387
SG - Singapore 2.766
CN - Cina 2.019
GB - Regno Unito 1.040
VN - Vietnam 1.006
BR - Brasile 963
HK - Hong Kong 876
DE - Germania 725
SE - Svezia 628
BD - Bangladesh 613
RU - Federazione Russa 364
FI - Finlandia 338
FR - Francia 331
CA - Canada 277
KR - Corea 252
IN - India 232
ID - Indonesia 219
NL - Olanda 191
AR - Argentina 140
TR - Turchia 138
JP - Giappone 134
UA - Ucraina 130
MX - Messico 126
BG - Bulgaria 87
ES - Italia 85
IE - Irlanda 80
IQ - Iraq 74
PL - Polonia 73
CO - Colombia 68
AU - Australia 67
ZA - Sudafrica 67
PK - Pakistan 63
LT - Lituania 56
RO - Romania 50
AT - Austria 48
AE - Emirati Arabi Uniti 44
BE - Belgio 42
EC - Ecuador 42
CL - Cile 41
CH - Svizzera 33
MA - Marocco 30
TW - Taiwan 30
CZ - Repubblica Ceca 29
MY - Malesia 29
VE - Venezuela 29
CR - Costa Rica 27
EG - Egitto 27
TH - Thailandia 27
JO - Giordania 25
UZ - Uzbekistan 23
SA - Arabia Saudita 22
DZ - Algeria 21
PH - Filippine 20
SI - Slovenia 20
IR - Iran 19
KE - Kenya 19
PY - Paraguay 19
GR - Grecia 18
NP - Nepal 17
JM - Giamaica 16
TN - Tunisia 16
NO - Norvegia 15
PE - Perù 15
AZ - Azerbaigian 14
DK - Danimarca 14
HU - Ungheria 13
IL - Israele 13
PT - Portogallo 13
KZ - Kazakistan 11
SN - Senegal 11
DO - Repubblica Dominicana 10
HR - Croazia 9
MD - Moldavia 9
OM - Oman 9
PR - Porto Rico 9
RS - Serbia 9
EE - Estonia 8
AL - Albania 7
GE - Georgia 7
LV - Lettonia 7
NI - Nicaragua 7
NZ - Nuova Zelanda 7
UY - Uruguay 7
BH - Bahrain 6
BY - Bielorussia 6
GA - Gabon 6
KG - Kirghizistan 6
LB - Libano 6
PA - Panama 6
SY - Repubblica araba siriana 6
TT - Trinidad e Tobago 6
BO - Bolivia 5
ET - Etiopia 5
HN - Honduras 5
LI - Liechtenstein 5
MK - Macedonia 5
PS - Palestinian Territory 5
QA - Qatar 5
A2 - ???statistics.table.value.countryCode.A2??? 4
Totale 35.449
Salva come PNG Salva come JPEG
Città #
Ashburn 1.922
Singapore 1.786
Santa Clara 1.517
Fairfield 1.279
San Jose 981
Hong Kong 849
Chandler 840
Council Bluffs 827
Woodbridge 595
Hefei 580
Houston 515
Seattle 474
Cambridge 408
Southend 399
Beijing 384
Wilmington 371
New York 366
London 361
Nyköping 349
Ho Chi Minh City 324
Milan 318
Los Angeles 313
Ann Arbor 307
Modena 274
Helsinki 242
Seoul 232
Hanoi 228
Chicago 224
San Diego 210
Bologna 198
Rome 192
Jakarta 188
The Dalles 173
Dearborn 160
Munich 158
Dallas 147
Jacksonville 127
Moscow 111
Shanghai 106
Lauterbourg 104
Tokyo 101
Buffalo 100
Princeton 96
São Paulo 96
Sofia 84
Orem 80
Toronto 78
Atlanta 70
Redwood City 68
Dublin 62
Grafing 62
Naples 62
Salt Lake City 61
Frankfurt am Main 60
Parma 60
Boardman 57
Mexico City 55
Warsaw 55
Montreal 52
Turin 52
Chennai 47
Mumbai 46
Nuremberg 46
Bremen 45
Da Nang 44
Elk Grove Village 44
Eugene 43
Lappeenranta 42
Verona 42
Phoenix 41
Poplar 41
Florence 40
Haiphong 39
North York 38
Reggio Emilia 38
Columbus 37
Denver 37
Sydney 36
Brooklyn 35
Miami 35
Rio de Janeiro 35
Hangzhou 33
Johannesburg 33
Ankara 32
Brussels 32
Turku 32
Guangzhou 31
Hillsboro 31
Kent 30
Baghdad 29
Tampa 29
Izmir 28
Stockholm 28
Amsterdam 27
Boston 27
Des Moines 27
Redondo Beach 27
Dong Ket 26
Palermo 26
Paris 26
Totale 21.955
Salva come PNG Salva come JPEG
Nome #
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 547
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 523
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 469
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 446
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 440
Acute exacerbation of Idiopathic Pulmonary Fibrosis: lessons learned from the Acute Respiratory Distress Syndrome 437
Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies. 420
Delirium and risk factors in patients undergoing non-invasive ventilation for de novo acute respiratory failure: an observational multicenter trial. 408
Acute severe asthma: management and treatment. 392
Insufficienza respiratoria acuta e cronica (cap.21). 389
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 383
Effectiveness of pulmonary rehabilitation in patients with INTERSTITIAL LUNG DISEASE of different etiology: a multicenter prospective study 382
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 381
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 375
Risk factors for pulmonary air leak and clinical prognosis in patients with COVID-19 related acute respiratory failure: a retrospective matched control study. 372
An uncommon cause of hemoptysis: aortobronchial fistula. 371
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 369
Incidence, etiology and clinico-pathologic features of endobronchial benign lesions: 10 consecutive years rerospective study 356
When Acute Respiratory Distress Syndrome is not ARDS 353
The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis 353
Integrated intErventional bronchoscopy in the treatment of locally adVanced non-small lung cancER with central Malignant airway Obstructions: a multicentric REtrospective study (EVERMORE). 345
Spontaneous breathing and evolving phenotypes of lung damage in patients with COVID-19. 345
An uncommon cause of pneumonia: The golden diagnosis 342
Comparison of Patients With or Without COVID-19 and Without Hematological Diseases Treated for Invasive Pulmonary Aspergillosis: A 5-Year Retrospective Cohort Study with Propensity-Based Adjustment 341
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy 341
Hypokalemia in Patients with COVID-19 337
Breathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure 336
Ventilatory support and mechanical properties of the fibrotic lung acting as a “squishy ball” 333
Serial Ultrasound Assessment of Diaphragmatic Function and Clinical Outcome in Patients with Amyotrophic Lateral Sclerosis. 332
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 332
Optimization of intranasal bleomycin dose for effective pulmonary fibrosis induction in mice with minimal animal distress. 330
Use of Pirfenidone in Idiopathic Pulmonary Fibrosis: A Case Study 329
Prevalence and outcome of diaphragmatic dysfunction assessed by ultrasound technology during acute exacerbation of chronic obstructive pulmonary disease: a pilot study. 329
Prevalence and development of chronic critical illness in acute patients admitted to a respiratory intensive care setting 327
Molecular Mechanisms and Physiological Changes behind Benign Tracheal and Subglottic Stenosis in Adults 327
Pulmonary stretch and lung mechanotransduction: Implications for progression in the fibrotic lung 324
Expression of HOXB7 in the lung of patients with idiopathic pulmonary fibrosis: a proof of concept study. 323
Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development. 323
Use of adjunctive cardiovascular therapy in patients hospitalized for acute exacerbations of COPD. 322
Breakthroughs in internal and respiratory medicine 315
Respiratory mechanics and diaphragmatic dysfunction in COPD patients who failed non-invasive mechanical ventilation 311
Early inspiratory effort assessment by esophageal manometry early predicts noninvasive ventilation outcome in de novo respiratory failure: a pilot study. 309
Peritoneal dialysis in the time of coronavirus disease 2019 308
Novel drug targets for idiopathic pulmonary fibrosis 304
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 303
Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players. 302
Inspiratory effort and respiratory mechanics in spontaneously breathing patients with acute exacerbation of idiopathic pulmonary fibrosis: a retrospective matched control study. 302
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 299
Early awake proning in critical and severe COVID-19 patients undergoing noninvasive respiratory support: A retrospective multicenter cohort study 288
COPD exacerbation and diaphragmatic dysfunction: Conditions with mutual influence influencing outcomes? - Reply. 286
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis 286
High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial 284
Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV2 infection: retrospective cohort study. 279
Looking for a Chronic Care Model in COPD patients 276
Ultrasound assessed Diaphragm Impairment is a Predictor of Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease undergoing Non-Invasive Ventilation. 276
COVIDGuide una app per il triage e l'autovalutazione della COVID-19. 273
Real-life comparison of Pirfenidone and Nintedanib in patients with Idiopathic Pulmonary Fibrosis: a 24-month assessment. 272
Never Give Up: lesson learned from a severe COVID-19 patient. 272
The encaged lung: rapidly progressive idiopathic pleurisy. 271
Effect of high flow nasal oxygen on inspiratory effort of patients with acute hypoxic respiratory failure and do not intubate order. 270
Atypical diagnosis for typical lung carcinoid 269
Ultrasound assessment of diaphragmatic function in patients with amyotrophic lateral sclerosis. 266
Nasal pressure swings as the measure of inspiratory effort in spontaneously breathing patients with de novo acute respiratory failure 265
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease 261
Endobronchial valve positioning for alveolar-pleural fistula following ICU management of severe COVID-19 pneumonia. 261
Inspiratory effort and lung mechanics in spontaneously breathing patients with acute respiratory failure due to COVID-19. A matched control study. 257
STenting veRsus balloOn dilatation in patients with tracheal BEnign stenosis – the STROBE trial. 254
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 253
Proprietà meccaniche e comportamento elastico del polmone affetto da fibrosi con pattern "polmonite interstiziale tipica" in corso di ventilazione meccanica: sviluppo e significato clinico della teoria del polmone "squishy ball" 253
Etiology and Level of Lung Derangement Do Not Affect the Beneficial Effect of Pulmonary Rehabilitation in Patients with Interstitial Lung Diseases 251
Biological effects of COVID-19 on lung cancer: can we drive our decisions? 245
The Effect Of Bronchodilators On Forced Vital Capacity In Patients With Idiopathic Pulmonary Fibrosis 240
Janus-faced amiodarone-induced pneumopathy 240
Endoscopic Bronchopleural Fistula Repair Using Autologous Fat Graft 240
Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges. 237
Impact of Mesenchymal Stromal/stem Cell Infusions on Circulating Inflammatory Biomarkers in COVID-19 Patients: Analysis of a Phase I-IIa Trial. 236
Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia. 235
Response Letter to Tuffet S, et al. and to Michard F, et al. 233
Dissecting the role of mesenchymal stem cells in idiopathic pulmonary fibrosis: cause or solution? 232
Changes in clinical characteristics and outcomes of patients admitted to inpatient cardiac rehabilitation 231
Vanishing lung emphysema during chemotherapy for malignant pleural mesothelioma. 229
An Italian sacrifice to COVID-19 epidemic. 229
Impaired function in the complex patient with COPD: a matter to be considered 228
Assessing respiratory drive and inspiratory effort in critically ill patients at the bedside 227
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 223
Differences between acute exacerbations of idiopathic pulmonary fibrosis and other interstitial lung diseases. 220
Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19 220
The association of procalcitonin and C- reactive protein with bacterial infections acquired during ICU stay in COVID-19 critically ill patients. 219
Physiological effects of lung protective ventilation in patients with lung fibrosis and usual interstitial pneumonia pattern versus primary ARDS: a matched-control study. 218
Association Between Pulmonary Aspergillosis And Cytomegalovirus Reactivation In Critically Ill Covid-19 Patients: A Prospective Observational Cohort Study. 215
Unusual effectiveness of systemic steroids in Whipple disease. 215
Development of clinical tools to estimate the breathing effort during high-flow oxygen therapy: A multicenter cohort study 213
Monitoring and modulation of respiratory drive in patients with acute hypoxemic respiratory failure in spontaneous breathing 212
Correction: Endobronchial valve positioning for alveolar-pleural fistula following ICU management complicating COVID-19 pneumonia (BMC Pulmonary Medicine, (2021), 21, 1, (307), 10.1186/s12890-021-01653-w) 212
Accuracy of nasal pressure swing to predict failure of high flow nasal oxygen in patients with acute hypoxemic respiratory failure 211
Extensive tracheal injuries: a reasoned multi-step approach to guarantee mechanical ventilatory support developed during COVID-19 pandemic. 211
An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of Hydroxychloroquine and chloroquine therapy 210
Feasibility and clinical impact of out-of-ICU noninvasive respiratory support in patients with COVID-19-related pneumonia 207
Critical COVID-19 Patients Through First, Second And Third Wave: Retrospective Observational Study Comparing Outcomes In ICU. 205
Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: a multicentre regional cohort study. 205
Totale 29.858
Salva come PNG Salva come JPEG
Categoria #
all - tutte 143.199
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 143.199
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.496 0 0 152 122 160 201 195 175 486 220 459 326
2022/20232.874 346 363 250 281 279 361 94 274 334 57 124 111
2023/20242.367 68 110 182 223 330 243 278 242 102 120 189 280
2024/20256.252 178 123 143 455 1.077 919 515 410 684 318 576 854
2025/202613.611 971 566 999 1.576 1.848 778 1.561 683 1.269 1.331 1.170 859
2026/20272.458 563 1.857 38 0 0 0 0 0 0 0 0 0
Totale 35.873